[The opportunities for genic therapy of chronic obliterating diseases of lower limbs arteries]

Khirurgiia (Mosk). 2014:(4):40-5.

[Article in Russian]

Authors

Iu A Cherviakov, I N Staroverov, E G Nersesian, O N Vlasenko, A A Isaev, R V Deev

PMID: 24816386

No abstract available

Publication types

Clinical Trial, Phase IV

MeSH terms

Adult
Angiogenesis Inducing Agents / therapeutic use
Drug Monitoring
Female
Genetic Therapy
Humans
Ischemia
Lower Extremity / blood supply*
Male
Neovascularization, Physiologic / genetics*
Peripheral Arterial Disease / physiopathology
Peripheral Arterial Disease / therapy*
Plasmids
Severity of Illness Index
Treatment Outcome
Vascular Endothelial Growth Factor A / genetics*
Vascular Endothelial Growth Factor A / therapeutic use

Substances

Angiogenesis Inducing Agents
VEGFA protein, human
Vascular Endothelial Growth Factor A